Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome

Weiwen Liu; Huihong Xu; Xihui Ying; Dengke Zhang; Linqiang Lai; Linyou Wang; Jianfei Tu; Jiansong Ji

doi:10.12659/MSM.923263

15 July 2020 : Clinical Research

Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome

Weiwen Liu^1ABC*, Huihong Xu^2DE, Xihui Ying^1EFG, Dengke Zhang^1CD, Linqiang Lai^1BC, Linyou Wang^3EF, Jianfei Tu^1CFG, Jiansong Ji^1BDG

DOI: 10.12659/MSM.923263

Med Sci Monit 2020; 26:e923263

Authors information Article notes Copyright and License information

Related articles Order reprints Share article Share by email

View HTML version

Figure 6 Patients who received TACE+RFA as the primary treatment had markedly longer OS compared with patients treated for recurrent tumors.

Back to the Article

Radiofrequency Ablation (RFA) Combined with Transcatheter Arterial Chemoembolization (TACE) for Patients with Medium-to-Large Hepatocellular Carcinoma: A Retrospective Analysis of Long-Term Outcome

Your Privacy